Overview

FUJI SILYSIA CHEMICAL LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering SYNTHETIC AMORPHOUS SILICA FOR CHROMATOGRAPHY PRODUCTS - CHROMATOREX; SYNTHETIC AMORPHOUS SILICA FOR NORMAL PHASE CHROMATOGRAPHY PRODUCTS - CHROMATOREX.

API / Drug Master Files

FUJI SILYSIA CHEMICAL LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • SYNTHETIC AMORPHOUS SILICA FOR CHROMATOGRAPHY PRODUCTS - CHROMATOREXActive2009-04-17
  • SYNTHETIC AMORPHOUS SILICA FOR NORMAL PHASE CHROMATOGRAPHY PRODUCTS - CHROMATOREXActive2008-02-20

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FUJI SILYSIA CHEMICAL LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.